How Difficult Is it to Scale Up an Amorphous Dispersion? (Xtalks article)

AustinPx’s Justin Keen, Senior Vice President, Operations explores the scaling up of KinetiSol Technology. This innovative, solvent-free process rapidly transforms active pharmaceutical ingredients into high-quality amorphous solid dispersions, enhancing solubility and bioavailability. KinetiSol simplifies scale-up by controlling a single variable – shear rate – making the transition from lab-scale to commercial production seamless and efficient.

Keen highlights how KinetiSol addresses the challenges of traditional techniques like hot melt extrusion and spray drying, offering a more sustainable and efficient solution for drug development. At AustinPx, we leverage KinetiSol to improve poorly soluble drug candidates, accelerate development timelines, and achieve cost savings, driving the future of pharmaceutical manufacturing.